Para poder acceder a la web de la GT debes tener el código de registro de la 8a edición de la Guía. No son válidos los códigos de ediciones anteriores. Si no has registrado tu código, debes hacerlo aquí.

Registrarse

¿Tienes cuenta y quieres actualizar tu código?

¿Has olvidado la contraseña?

Para cualquier consulta o incidencia, puedes contactarnos a través del correo guiaterapeutica@semfyc.es

Volver a bibliografía

Problemas de la cara-nariz-boca-garganta-oídos

Acúfenos

  • Agency for Healthcare Research and Quality. Evaluation and treatment of tinnitus: Comparative effectiveness; 2013. https://effectivehealthcare.ahrq.gov/topics/tinnitus/research
  • Biesinger E, Del Bo L, De Ridder D, and cols. Algorithm for the diagnostic and therapeutic management of tinnitus. TRI Tinnitus Clinic Network. 2010.
  • Folmer R, Hal M, Yongbing S. Tinnitus: Questions to reveal the cause, answers to provide relief. J Fam Pract 2004.
  • Hoare DJ, Edmondson-Jones M, Sereda M, Akeroyd MA, Hall D. Amplification with hearing aids for patients with tinnitus and co-existing hearing loss. Cochrane Database Syst Rev. 2014;1:CD010151.
  • Hoare DJ, Kowalkowski VL, Kang S, Hall DA. Systematic review and meta-analyses of randomized controlled trials examining tinnitus management. Laryngoscope. 2011;121(7):1555.
  • Martínez-Devesa P, Perera R, Theodoulou M, Waddell A. Terapia cognitivo conductual para el tinnitus. Cochrane Database of Systematic Reviews 2010 Issue 9. Art. No.: CD005233.
  • Parazzini M, Del Bo L, Jastreboff M, Tognola G, Ravazzani P. Open ear hearing aids in tinnitus therapy: An efficacy comparison with sound generators. Int J Audiol. 2011 Aug;50(8):548-53. Epub 2011 May 19.
  • Tinnitus: assessment and management. NICE guideline Published: 11 March 2020. Disponible en: http://www.nice.org.uk/guidance/ng155
  • Tunkel D, Bauer C. Clinical Practice Guideline: Tinnitus. Otolaryngology–Head and Neck Surgery 2014, Vol. 151(2S) S1–S40. Disponible en: https://journals.sagepub.com/doi/pdf/10.1177/0194599814545325
  • Waddel A. Acúfenos. En: Centro Cochane Iberoamericano. Evidencia clínica concisa. Bogotá: Legis; 2006-07:464-6.

Afta bucal

  • Edgar NR, Saleh D, Miller RA. Recurrent Aphthous Stomatitis: A Review. J Clin Aesthet Dermatol 2017; 10:26.
  • Liu C, Zhou Z, Liu G, et al. Efficacy and safety of dexamethasone ointment on recurrent aphthous ulceration. Am J Med 2012; 125:292.
  • Prodigy Guidance 2007 [acceso Jul 2008]. Disponible en: http://www. prodigy.nhs.uk/
  • Purriños L, Fernández-Obanza E. Aftas orales. AMF 2008;4(1):38-40.
  • Scully C, Porter S. Enfermedad de la mucosa oral: estomatitis aftosa recurrente. Br J Oral Maxillofac Surg 2008; 46: 198.
  • Tarakji B, Gazal G, Al-Maweri SA, et al. Guideline for the diagnosis and treatment of recurrent aphthous stomatitis for dental practitioners. J Int Oral Health 2015; 7:74.

Candidiasis oral

  • Akpan A, Morgan R. Oral candidiasis. Postgraduate Medical Journal. 2002;78(922):455-9.
  • Clarkson JE, Worthington HV, Eden OB. Intervenciones para la prevención de la candidiasis oral en pacientes con cáncer que reciben tratamiento (Revisión Cochrane traducida). En: Biblioteca Cochrane Plus, 2008, número 2. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com
  • DynaMed Plus [Internet]. Ipswich (MA): EBSCO Information Services. 1995 - . Record No. 114902, Oral candidiasis; [updated 2016 Apr 14, consultado 7 sept 2018]; http://www.dynamed.com/login.aspx?direct=true&site=DynaMed&id=114902
  • Monedero M, García C, Rabanaque G, Marín P, Batalla M. Protocolo de tratamiento empírico de las infecciones en el adulto. FMC 2007;14:30-6.
  • Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. [Consulta realizada el 29 de septiembre de 2019]. Disponible en: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf
  • Su CW, Gaskie S, Jamieson B, Triezenberg D. What is the best treatment for oral thrush in healthy infants? Journal of Family Practice July. 2008;vol.57,No.7:484-5.

Disfonía

  • Amor JC, Costa C. Disfonía. [Internet.] Guías clínicas Fisterra. 2015. Disponible en: www.fisterra.com/guías-clínicas/disfonia/
  • Bruch J, Kamani D. Hoarseness in adults. [Internet.] UpToDate 2016. Disponible en: http://www.uptodate.com
  • Chang JI, Bevans SE, Schwartz SR. Otolaryngology clinic of North America: evidence based practice: management of hoarseness/dysphonia. Otolaryngol Clin North Am. 2012;45(5):1109-26.
  • Romero E, Martín A, De Mier M. Disfonía. FMC 2008;15(2):62-9.
  • Ruotsalainen JH, Sellman J, Lehto L, Jauhiainen M, Verbeek JH. Intervenciones para el tratamiento de la disfonía funcional en adultos (Revisión Cochrane traducida). En: Biblioteca Cochrane Plus, 2008, número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com

Disfunción de la articulación temporomandibular

  • Buescher JJ. Temporomandibular joint disorders. American Family Physician. 2007;76 (10):1477-82.

  • Gauer RL, Semidey MJ. Diagnosis and treatment of temporomandibular disorders. Am Fam Physician. 2015 Mar 15;91(6):378-86. PMID: 25822556.

  • Koh H, Robinson P. Occlusal adjustment for treating and preventing temporomandibular joint disorders. Cochrane Database of Systematic Reviews 2003, Issue 1. Art. No.: CD003812.
  • Manfredini D, Lobbezoo F. A systematic review of the effectiveness of exercise, manual therapy, electrotherapy, relaxation training, and biofeedback in the management of temporomandibular disorder. Physical Therapy. 2010;86(7):955-73.
  • Medlicott MS, Harris AR. Una revisión sistemática de la efectividad del ejercicio, terapia manual, electroterapia, ejercicios de relajación y biofeedback en el tratamiento del trastorno temporomandibular. Hay Phys. 2006 Jul;86(7):955-73.
  • Revisión de las directrices para el tratamiento de los trastornos temporomandibulares conjunto aprobado por el "Consejo de la AADR" 3 marzo de 2010. [Artículo Diario, Guía de Práctica]. Rev Med Dent Belge (1984). 2010 Oct-Dec;65(4):163-4.

Dolor dental y periodontal

  • Agnihotry A, Thompson W, Fedorowicz Z, van Zuuren EJ and Sprakel J. Antibiotic use for irreversible pulpitis. Cochrane Database Syst Rev.; 2016 Feb. Prim Dent J. 2014 Feb;3(1):52-7.
  • Bascones A, Aguirre J, Bermejo A. Documento de consenso sobre el tratamiento antimicrobiano de las infecciones bacterianas odontogénicas. Av Odontoestomatol. 2005;21:311-9.
  • Calsina E, Vichino S. Enfermedad periodontal. Formación Médica Continuada. 2001;2:68-76.
  • Cope A al. Systemic antibiotics for symptomatic apical periodontitis and acute apical abscess in adults. Cochrane Database Syst Rev.; 2014 Jun 26; 6.
  • Daly CG. Antibiotic prophylaxis for dental procedures. Aust Prescr 2017;40:184-8.
  • Dental abscess – Management Institute for Clinical Systems Improvement. 2008 Ene. Natinal Guideline Clearinghouse. [Actualizada Ene 2008; acceso 9 Jul 2008]. Disponible en: http://www.prodigy.nhs.uk/dental_abscess
  • Douglas PR. Management of severe acute dental infections. BMJ 2015; 350.
  • Monedero M, García C, Rabanaque G, Marín P, Batalla M. Tratamiento empírico de las infecciones en el adulto. FMC 2008;Protocolo 4/2008 30-5.
  • Prevention and treatment of periodontal diseases in Primary Care.2014. Dental Clinical Guidance. Scottish Dental Clinical Effectiveness Programme. Disponible en: http://www.sdcep.org.uk
  • Segura-Egea JJ, Gould K, Şen BH, Jonasson P, Cotti E, Mazzoni A, et al. European Society of Endodontology position statement: the use of antibiotics in endodontics. Int Endod J 2018;51:20-5.
  • Timmerman A, Parashos P. Management of dental pain in primary care. Aust Prescr. 2020;43(2):39-44. doi:10.18773/austprescr.2020.010.

Epistaxis

  • Bequignon E, Vérillaud B, Robard L, et al; SFORL work-group. Guidelines of the French Society of Otorhinolaryngology (Société Française d'Oto-Rhino-Laryngologie [SFORL]). First-line treatment of epistaxis in adults. Eur Ann Otorhinolaryngol Head Neck Dis. 2017 May;134(3):185-189
  • Biswas D, Mal RK. Are systemic prophylactic antibiotics indicated with anterior nasal packing for spontaneous epistaxis? Acta Otolaryngol. 2009 Feb;129(2):179-81.
  • García E, González X. Técnica para la colocación de un taponamiento nasal anterior. AMF 2006:2(1):29-32.
  • García S, Millán J. Epistaxis. 2016. Disponible en: http://www.fisterra.com/fisterrae/
  • Pennekamp A, Tschirky P, Grossenbacher R. Importancia de Staphylococcus aureus en las operaciones de la nariz. Riesgo de síndrome de shock tóxico. ENT. 1995;43(11):664.
  • Pepper C, Lo S, Toma AJ. Prospective study of the risk of not using prophylactic antibiotics in nasal packing for epistaxis. Laryngol Otol. 2012 Mar;126(3):257-9.

  • Tunkel D, Anne S, MD Clinical Practice Guideline: Nosebleed (Epistaxis) Otolaryngology–Head and Neck Surgery 2020, Vol. 162(1S) S1–S38. Disponible en: https://journals.sagepub.com/doi/pdf/10.1177/0194599819890327

Faringitis

  • Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. Circulation 2009; 119:1541.
  • Llor C, Moragas A. Infecciones del tracto respiratorio. AMF 2021; 17(11):632-43.
  • Michigan Quality Improvement Consortium. Acute pharyngitis in children 2-18 years old. Southfield (MI): Michigan Quality Improvement Consortium; 2011 Jan.
  • NICE guideline [NG84]. Sore throat (acute): antimicrobial prescribing. Jan 2018, Disponible en : www.nice.org.uk/guidance/ng84
  • Picazo J, Betriu C, Rodríguez-Avial I, Gómez M, Culebras E. Vigilancia de resistencias a los antimicrobianos: estudio VIRA 2004. Microbiol Clin. 2004;22(9);517-25.
  • Pichichero ME. Treatment adn prevention of streptococcal pharyngitis in adults and children. In UpToDate 223.
  • Piñeiro R, Hijano F, Älvez F, Fernández A, Silva JC, Pérez C, et al. Documento de consenso sobre el diagnóstico y tratamiento de la faringoamigdalitis aguda. An Pediatr (Barc). 2011;75(5):342.e1-342.e13.
  • Spinks A, Glasziou PP, Del Mar CB. Antibiotics for treatment of sore throat in children and adults. Cochrane Database of Systematic Reviews 2021, Issue 12. Art. No.: CD000023. DOI: 10.1002/14651858.CD000023.pub5. Consultado el 13 de septiembre de 2023.
  • Stelter K. [Tonsillitis and sore throat in childhood]. Laryngorhinootologie. 2014 Mar;93 Suppl 1: S84-102.
  • Van Driel ML, De Sutter AIM, Thorning S, Christiaens T. Diferentes tratamientos con antibióticos para la faringitis estreptocócica del grupo A. Base de datos Cochrane de revisiones sistemáticas 2021, número 3. Art. No.: CD004406. DOI: 10.1002/14651858.CD004406.pub5. Consultado el 13 de septiembre de 2023.

Glositis. Gingivitis

Halitosis

  • Cabrera A, Brea M. A propósito de un caso de halitosis. FMC. 2006;13:19-20.
  • Castiñeira C, Boyero L, Rodriguez C, Ollarves J. Halitosis. 2017. [consulta realizada el 10 Sep 2018]. Disponible en: http://www.fisterra.com/fisterrae/guias
  • Martínez A. Halitosis. AMF 2007:3(6):334-7.
  • Monfort Codinach M., Jané Salas E.. Halitosis: diagnóstico y tratamiento. Av Odontoestomatol [Internet]. 2014 Jun [citado 2018 Sep 29] ; 30( 3 ): 155-160. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0213-12852014000300009&lng=es
  • Pedrazzi V, Nascimento C, Mardegan Issa JP, Fedorowicz Z. Intervenciones para el manejo de la halitosis. Base de Datos Cochrane de Revisiones Sistemáticas 2016, Número 5. Arte. No .: CD012213.
  • Porter S, Scully C. Oral malodour (halitosis). BMJ 2006;333:632-5.
  • Seemann R1, Conceicao MD, Filippi A, Greenman J, Lenton P, Nachnani S, Quirynen M, Roldan S, Schulze H, Sterer N, Tangerman A, Winkel EG, Yaegaki K, Rosenberg M. Halitosis management by the general dental practitioner--results of an international consensus workshop. J Breath Res. 2014 Mar;8(1):017101.

Laringitis aguda. Laringitis crónica. Crup

  • Alberta Clinical Practice Guidelines/Toward Optimized Practice (TOP). Guideline on diagnosis and management of croup. TOP 2008 Jan. http://topalbertadoctors.org/download/252/croup_guideline.pdf?_20180930180953
  • Aregbesola A, Tam CM, Kothari A, et al. Glucocorticoids for croup in children. Cochrane Database Syst Rev 2023; 1:CD001955.
  • Bjornson CL, Johnson DW. Croup. Lancet 2008;371:329-39.
  • Callén M, Cortés O. El Pediatra de Atención Primaria y la Laringitis Aguda – Crup. Protocolos del GVR (publicación P-GVR-5). 2010 [consulta realizada el 20 Feb 2012]. Disponible en: www.aepap.org/gvr/protocolos.htm
  • Cherry JD. Croup. N Engl J Med 2008;358:384-91.
  • Clinical Evidence. Croup. [consulta realizada el 3 Jul 2008]. Disponible en: www.clinicalevidence.com
  • DynaMed Plus [Internet]. Ipswich (MA): Servicios de información EBSCO. 1995 -. Registro No. 115115, Laringitis; [actualizado 2018 ago, Consulta realizada el 30 Sep 2018]; Disponible en: http://www.dynamed.com/login.aspx?direct=true&site=DynaMed&id=115115
  • Petrocheilou A1, Tanou K, Kalampouka E, Malakasioti G, Giannios C, Kaditis AG. Viral croup: diagnosis and a treatment algorithm. Pediatr Pulmonol. 2014 May;49(5):421-9.
  • Reveiz L, Cardona AF. Antibióticos para la laringitis aguda en adultos. Base de datos Cochrane de revisiones sistemáticas 2015, número 5. Art. No.: CD004783. DOI: 10.1002/14651858.CD004783.pub5. Consultado el 13 de septiembre de 2023.
  • Smith D, McDermott A, Sullivan J. Croup: Diagnosis and Management. Am Fam Physician. 2018 May 1;97(9):575-580.
  • Wood J, Athanasiadis T, Allen J. Laryngitis. BMJ 2014; 349: g5827

Litiasis salivar

  • Guerra A, Katz P. Litotricia extracorpórea por ondas de choque (LEOC) de las piedras de glándulas salivales: Estudio retrospectivo de 1.571 pacientes. Rev Maxilofac Stomatol Chir. 2011 Apr;112(2):75-9.
  • Iro H, Zenk J, Escudier MP, Nahlieli O, Capaccio P, Katz P, et al. Outcome of minimally invasive management of salivary calculi in 4,691 patients. Laryngoscope. 2009;119(2):263.
  • Koch M, Zenk J, Iro H. Algoritmos para el tratamiento de las obstrucciones glándula salival. Otolaryngol Clin North Am. 2009 Dec;42(6):1173-92.
  • Roccia P, Di Liberto C, Speciale R, La Torretta G, Lo Muzio L, Campisi G. Sialoadenitis obstructiva: actualización de las cuestiones de diagnóstico y terapia. Recenti Prog Med. 2006 May;97(5):272-9.

Otitis externa aguda

  • Costa C, Amor JC. Otitis externa. Fisterra 2017. Disponible en: http://www.fisterra.com/fisterrae
  • Goguen L, Durand, M.Otitis externa, In UpTo Date 2023.
  • Lee A, Tysome JR, Saeed SR. Tratamientos tópicos con azol para la otomicosis. Base de datos Cochrane de revisiones sistemáticas 2021, número 5. Art. No.: CD009289. DOI: 10.1002/14651858.CD009289.pub2. Consultado el 11 de septiembre de 2023.
  • Pistorius, B, Westburry, K, Drehobl, M. Prospective, randomized, comparative trial of ciprofloxacin otic drops, with or without hydrocortisone, vs. polymyxin B-neomycin-hydrocortisone otic suspension in the treatment of acute diffuse otitis externa. Infect Dis Clin Pract. 1999;8:387-395. Disponible en: https://insights.ovid.com/crossref?an=00019048-199911000-00009
  • Roberts DB. La etiología de la miringitis bullosa y el papel de los micoplasmas en enfermedades del oído: una revisión. Pediatrics. 1980 Apr;65(4):761-6.
  • Rosenfeld RM, Schwartz SR, Cannon CR, et al; American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 Suppl):S1-S24. http://journals.sagepub.com/doi/full/10.1177/0194599813517083
  • Sander R. Otitis externa: una guía práctica para el tratamiento y la prevención. Fam Physician Soy. 2001 Mar 1;63(5):927-36, 941-2.
  • Vivek Kaushik, Tass Malik, Shakeel R Saeed. Intervenciones para la otitis externa aguda (Revision Cochrane traducida). En: Biblioteca Cochrane Plus 2010, Número 1. Oxford: Update Software Ltd. Disponible en: https://www.cochrane.org/es/CD004740 (Traducida de The Cochrane Library, 2010 Issue 1 Art no. CD004740. Chichester, UK: John Wiley & Sons, Ltd.).
  • Vennewald I, E Klemm. Otomycosis: Diagnosis and treatment. Dermatol Clin. 2010;28(2):202-11.

Otitis media crónica simple

  • Macfadyen CA, Acuin JM, Gamble C. Antibióticos tópicos sin esteroides para la secreción ótica crónica con perforación de tímpano subyacente (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2008, Número 4. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com
  • WHO. Chronic suppurative otitis media. Burden of illness and management options. 2004.

Otitis media serosa

  • Griffin G, Flynn CA. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database of Systematic Reviews, September 2011.

  • Perera R, Glasziou PP, Heneghan CJ, McLellan J, Williamson I. Autoinflation for hearing loss associated with otitis media with effusion. Cochrane Database of Systematic Reviews 2013, Issue 5. Art. No.: CD006285. DOI: 10.1002/14651858.CD006285.pub2.

  • Principi N, Marchisio P, Esposito S. Otitis media with effusion: benefits and harms of strategies in use for treatment and prevention. Expert Rev Anti Infect Ther. 2016;14(4):415-23. doi: 10.1586/14787210.2016.1150781. Epub 2016 Feb 26.
  • Simpson SA, Lewis R, van der Voort J, Butler CC. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD001935. DOI: 10.1002/14651858.CD001935.pub3.
  • Steel D, Adam GP, Di M, Halladay C, Pan I, Coppersmith N, Balk EM, Trikalinos TA. ympanostomy Tubes in Children With Otitis Media. Comparative Effectiveness Review No. 185. (Prepared by the Brown Evidence-based Practice Center under Contract No. 290-2015-00002-I.) AHRQ Publication No. 17-EHC003-EF. Rockville, MD: Agency for Healthcare Research and Quality; May 2017. www.effectivehealthcare.ahrq.gov/reports/final.cfm. doi: https://doi.org/10.23970/AHRQEPCCER185Link to Exit Disclaimer.
  • Rosenfeld R, Shin J, Schwartz S. Clinical Practice Guideline: Otitis Media with Effusion (Update). Otolaryngology–Head and Neck Surgery. Vol 154, Issue 1_suppl, pp. S1 - S41 First Published February 1, 2016 https://doi.org/10.1177/0194599815623467

  • Venekamp RP, Burton MJ, van Dongen TMA, van der Heijden GJ, van Zon A, Schilder AGM. Antibiotics for otitis media with effusion in children. Cochrane Database of Systematic Reviews 2016, Issue 6. Art. No.: CD009163. DOI: 10.1002/14651858.CD009163.pub3.

  • Venekamp RP, Mick P, Schilder AG, Nunez DA. Grommets (ventilation tubes) for recurrent acute otitis media in children. Cochrane Database Syst Rev. 2018 May 9;5:CD012017. doi: 10.1002/14651858.CD012017.pub2.

Otitis media aguda simple o supurada

  • Damoiseaux AR, Rovers MM. OMA en niños. Clin Evid (en línea). 2011.
  • Del Castillo F, Delgado A, Rodrigo C, Cervera J, Villafruela MA, Picazo JJ. Consenso Nacional sobre otitis media aguda. An Pediatr (Barc). 2007;66(6):603-10. Disponible en: https://www.analesdepediatria.org/es-consenso-nacional-sobre-otitis-media-articulo-13107396
  • Limb CJ, Lustig LR. Acute otitis media in adults. In: UpToDate 2023.
  • Llor C, Moragas A. Infecciones del tracto respiratorio. AMF 2021; 17(11):632-43.
  • National Guideline Clearinghouse (NGC). Guideline summary: Otitis media. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); Abr 2013. Disponible en : https://www.guideline.gov
  • NICE guideline [NG91] Otitis media (acute): antimicrobial prescribing National Institute for Health adn Care Excellence (NICE); 2023. Disponible en: https://www.nice.org.uk/Guidance/NG91
  • University of Michigan Health System. Otitis Media Guideline. [Internet]. Ann Arbor: 2013 Disponible en: http://www.med.umich.edu/1info/FHP/practiceguides/om/OM.pdf
  • Venekamp RP, Sanders SL, Glasziou PP, et al. Antibióticos para la otitis media aguda en niños. Sistema de base de datos Cochrane Rev 2015. CD000219.

Pérdida traumática de un diente

  • Day P, Duggal M. Intervenciones para el tratamiento de los dientes frontales permanentes traumatizados: avulsionados (expulsados) y recolocados (Revision Cochrane traducida). En: Biblioteca Cochrane Plus 2010 Número 1. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com.
  • Flores MT, Andersson L, Andreasen JO, Bakland LK, Malmgren B, Barnett F, et al. Guidelines for the management of traumatic dental injuries. Dental Tratumatology. 2007;23:66-71.
  • Rodríguez M, Naya C, Blanco E. Traumatismos dentales. 2001. Fisterrae 2011. Disponible en: http://www.fisterra.com/fisterrae/
  • Scottish Dental. Clinical Effectiveness Programme. Management of Acute Dental Problems. Guidance for healthcare professionals. Disponible en http://www.sdcep.org.uk/wp-content/uploads/2013/03/SDCEP+MADP+Guidance+March+2013.pdf

Poliposis nasal

  • Amor J, Costa C. Poliposis nasal. Fisterra 2018.
  • Becker SS. Manejo quirúrgico de pólipos en el tratamiento de la obstrucción de la vía aérea nasal. Otolaryngol Clin North Am 2009; 42: 377.
  • Cabeza K , Chong LY , Hopkins C , Philpott C , Schilder AGM , Burton MJ . Esteroides orales de curso corto como terapia adjunta para la rinosinusitis crónica . Base de Datos Cochrane de Revisiones Sistemáticas 2016 , Número 4 . Art. No .: CD011992. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD011992.pub2/full
  • Chong LY, Piromchai P, Sharp S, Snidvongs K, Webster KE, Philpott C, Hopkins C, Burton MJ. Biologics for chronic rhinosinusitis. Cochrane Database Syst Rev. 2021 Mar 12;3(3):CD013513. doi: 10.1002/14651858.CD013513.pub3. PMID: 33710614; PMCID: PMC8094915.
  • Fokkens WJ, Viskens AS, Backer V, et al. EPOS/EUFOREA update on indication and evaluation of Biologics in Chronic Rhinosinusitis with Nasal Polyps 2023. Rhinology 2023; 61:194.
  • Newton JR, Ah-See KW. Una revisión de la poliposis nasal. Ther Clin Risk Manag 2008; 4: 507.
  • Rank MA, Chu DK, Bognanni A, et al. The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2023; 151:386.
  • Roland LT, Smith TL, Schlosser RJ, et al. Guidance for contemporary use of biologics in management of chronic rhinosinusitis with nasal polyps: discussion from a National Institutes of Health-sponsored workshop. Int Forum Allergy Rhinol 2020; 10:1037.
  • Rozsasi A, Polzehl D, Deutschle T, Smith E, Wiesmiller K, Riechelmann H, Keck T. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily. Allergy. 2008 Sep;63(9):1228-34. doi: 10.1111/j.1398-9995.2008.01658.x. PMID: 18699939.

Queilitis angular

  • García E, Blanco A, Rodríguez L, Reyes D, Sotres J. Queilitis. Revisión bibliográfica. Rev Cubana Estomatol. 2003;40(3).
  • Johnson VB, Chalmers J. Oral hygiene care for functionally dependent and cognitively impaired older adults. Iowa City (IA): University of Iowa College of Nursing, John A. Hartford Foundation Center of Geriatric Nursing Excellence; 2011 Jul. 61 p.

Resfriado común

  • Deckx L , De Sutter AIM , Guo L , Mir NA , van Driel ML . Descongestionantes nasales en monoterapia para el resfriado común . Base de datos Cochrane de revisiones sistemáticas 2016 , edición 10 . Art. No .: CD009612. DOI: 10.1002 / 14651858.CD009612.pub2. . Consulta realizada el 10 Sep 2018] Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009612.pub2/full
  • Harris AM, Hicks LA, Qaseem A, for the High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention.Appropriate antibiotic use for acute respiratory tract infection in adults: Advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention.Ann Intern Med. 2016;164:425–34.
  • Hemilä H , Chalker E . Vitamina C para prevenir y tratar el resfriado común . Base de datos Cochrane de revisiones sistemáticas 2013 , edición 1 . Art. No .: CD000980. DOI: 10.1002 / 14651858.CD000980.pub4. Consulta realizada el 10 Sep 2018]. Disponible en: http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD000980.pub4/full
  • Little P, Stuart B, Mullee M, Thomas T, Johnson S, Leydon G, et al; for the SNIFS Study Team. Effectiveness of steam inhalation and nasal irrigation for chronic or recurrent sinus symptoms in primary care: a pragmatic randomized controlled trial. CMAJ. 2016;188:940–9.
  • Sexton D, McClain M. the common cold in adults treatment and prevention. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. (Allan, G. Michael, and Bruce Arroll. “Prevention and Treatment of the Common Cold: Making Sense of the Evidence.” CMAJ : Canadian Medical Association Journal 186.3 (2014): 190–199. PMC. Web. 8 Oct. 2018.Acceso 11 Nov 2017). Disponible en: http://www.uptodate.com
  • De Sutter AIM, Eriksson L, van Driel ML. Combinaciones de antihistamínicos, descongestionantes y analgésicos orales para el resfriado común. Base de datos Cochrane de revisiones sistemáticas 2022, número 1. Art. No.: CD004976. DOI: 10.1002/14651858.CD004976.pub4. Consultado el 11 de septiembre de 2023.

Rinitis alérgica

  • Bousquet J, Anto JM, Bachert C, Baiardini I, Bosnic-Anticevich S, Walter Canonica G, Melén E, Palomares O, Scadding GK, Togias A, Toppila-Salmi S. Allergic rhinitis. Nat Rev Dis Primers. 2020 Dec 3;6(1):95. doi: 10.1038/s41572-020-00227-0. PMID: 33273461.
  • Bousquet, J. et al. 2019 ARIA care pathways for allergen immunotherapy. Allergy 74, 2087-2102 (2019).
  • Dykewicz MS, Wallace DV, Amrol DJ y cols. Rinitis 2020: una actualización de parámetros de práctica. J Alergia Clin Immunol 2020; 146:721.
  • Fokkens WJ, Lund VJ, Mullol J. European Position Paper on Nasal Polyps Rhinology. 2007; 45(suppl 20):1-139.
  • Jacob E. Pólipos nasales 2008. Fisterrae. Disponible en :www.fisterra.com/fisterrae
  • Martín A, Romero E, De Mier M. La obstrucción nasal crónica. FMC. 2006:13:112-21.

  • Nurmatov U, Dhami S, Arasi S, Roberts G, Pfaar O, Muraro A, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews. Clin Transl Allergy. 2017 Aug 8;7:24. doi: 10.1186/s13601-017-0159-6. PMID: 28794855; PMCID: PMC5547534.

  • Romero E, Martín A, De Mier M, Maqueda T, Lahoz B. Guía de rinitis 2006. [Consultada el 11 jul 2008]. Disponible en: http://www.fisterra.com/fisterrae/
  • Scadding GK, Durham SR, Mirakian R, Jones NS, Drake-Lee AB, Ryan D, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy. 2008;38(2):260-75.
  • Sheikh A, Hurwitz B, Nurmatov U, van Schayck CP. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database of Systematic Reviews 2010, Issue 7. Art. No.: CD001563. DOI: 10.1002/14651858.CD001563.pub3.
  • Schuler Iv CF, Montejo JM. Allergic Rhinitis in Children and Adolescents. Pediatr Clin North Am. 2019 Oct;66(5):981-993. doi: 10.1016/j.pcl.2019.06.004. Epub 2019 Aug 5. PMID: 31466686.

Rinitis farmacológica

  • DynaMed Plus [Internet]. Ipswich (MA): EBSCO Information Services. 1995 - . Record No. 116234, Rhinitis medicamentosa; [updated 2018 Jan 04]. Disponible en: http://www.dynamed.com/login.aspx?direct=true&site=DynaMed&id=116234. Registration and login required.
  • Wallace DV, Dykewicz MS, Bernstein DI, Blessing-Moore J, Cox L, Khan DA, et al, Joint Task Force on Practice, American Academy of Allergy, Asthma & Immunology, American College of Allergy, Asthma and Immunology, Joint Council of Allergy, Asthma and Immunology. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008 Aug;122(2 Suppl):S1-84.

Rinitis vasomotora

  • 2007 Annual evidence update on rhinitis: non-allergic rhinitis. Disponible en: http://www.library.nhs.uk/ent/ViewResource.aspx?resID=260110
  • Banov CH, Lieberman P; Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol. 2001 Jan;86(1):28-35.
  • Ciprandi G. Treatment of nonallergic perennial rhinitis. Allergy. 2004;59(Suppl 76):16-22.
  • DynaMed Plus [Internet]. Ipswich (MA): EBSCO Information Services. 1995 - . Record No. 114903, Vasomotor rhinitis; [updated 2015 Aug 07]; Disponible en: http://www.dynamed.com/login.aspx?direct=true&site=DynaMed&id=114903. Registration and login required.
  • Gehanno P, Deschamps E, Garay E, Baehre M, Garay RP. Vasomotor rhinitis: clinical efficacy of azelastine nasal spray in comparison with placebo. ORL J Otorhinolaryngol Relat Spec. 2001 Mar-Apr;63(2):76-81.
  • Pattanaik D,Lieberman P. Vasomotor Rhinitis. Curr Allergy Asthma Rep. 2010;10(2):84-91, 215.
  • Scadding GK, Durham SR, Mirakian R, et al. BSACI guidelines for the management of allergic and non-allergic rhinitis. Clinical and Experimental Allergy. 2008;38(1):19-42.

Sinusitis aguda

  • Castiñeiras C, Jacob E, Amor J. Rinosinusitis aguda 2020. Fisterra. [acceso 10 Sep 2023].
  • DynaMed [Internet]. Rinosinusitis aguda en niños. Update 2023. Servicios de información de EBSCO. Consultado el 3 de septiembre de 2023. Disponible en: https://www.dynamed.com/condition/acute-rhinosinusitis-in-children
  • Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020;58(Suppl S29):1-464. doi: 10.4193/Rhin20.600.
  • Gallant JN, Basem JI, Turner JH, Shannon CN, Virgin FW. Nasal saline irrigation in pediatric rhinosinusitis: A systematic review. Int J Pediatr Otorhinolaryngol. 2018;108:155-62. doi: 10.1016/j.ijporl.2018.03.001.
  • Hughes PR, Hungerford CH, Jensen KN. Acute rhinosinusitis: When to prescribe an antibiotic. J Fam Pract. 2020;69(5):244-50.
  • Kanjanawasee D, Seresirikachorn K, Chitsuthipakorn W, Snidvongs K. Hypertonic Saline Versus Isotonic Saline Nasal Irrigation: Systematic Review and Meta-analysis. Am J Rhinol Allergy. 2018;32(4):269-79. PubMed PMID: 29774747
  • Lemiengre MB, van Driel ML, Merenstein D, Liira H, Mäkelä M, De Sutter AIM. Antibiotics for acute rhinosinusitis in adults. Cochrane Database of Systematic Reviews 2018, Issue 9. Art. No.: CD006089. DOI: 10.1002/14651858.CD006089.pub5. Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD006089.pub5/full/es
  • Martínez Campos L., Albañil Ballesteros R., Flor Bru J. de la, Piñeiro Pérez R., Cervera J., Baquero Artigao F. et al. Documento de consenso sobre etiología, diagnóstico y tratamiento de la sinusitis. Rev Pediatr Aten Primaria [Internet]. 2013 Sep [citado 2019 Oct 07]; 15( 59 ): 203-218. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1139-76322013000400002&lng=es. http://dx.doi.org/10.4321/S1139-76322013000400002.
  • Moragas A, Llor C. Infecciones del tracto respiratorio superior. AMF 2021;17(11):632-43.
  • Muguruza A, Cámara A, Arranz L, Abrego M. Rinosinusitis aguda. OSI Donostialdea. Guía de tratamiento de las enfermedades infecciosas en atención primaria (Pediatría). 2017. P 48-49.
  • National Institute for Health and Care Excellence. Sinusitis (acute): antimicrobial prescribing. NICE guideline; 2017.
  • Orlandi R, Kingdom T, Hwang P, Smith T. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016 Feb;6 Suppl 1:S22-209. doi: 10.1002/alr.21695.
  • Patel ZM, Hwang PH. Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis. En: Deschler DG, File TM, Kunins L, editors. UpToDate; 2023. Disponible en: https://www.uptodate.com/contents/acute-sinusitis-and-rhinosinusitis-in-adults-clinical-manifestations-and-diagnosishttps://www.uptodate.com/contents/acute-sinusitis-and-rhinosinusitis-in-adults-clinical-manifestations-and-diagnosisVenekamp RP, Thompson MJ, Hayward G, et al. Corticosteroides sistémicos para la sinusitis aguda. Base de datos Cochrane Syst Rev 2014; : CD008115.
  • Wilson J. Acute Sinusitis. Ann Intern Med. 2010;153:ITC3-1.
  • Zalmanovici Trestioreanu A, Yaphe J. Esteroides intranasales para la sinusitis aguda. Base de datos Cochrane Syst Rev 2013; : CD005149.

Sinusitis crónica

  • Ah-See KL, MacKenzie J, Ah-See KW. Management of chronic rhinosinusitis. BMJ. 2012 Oct 30;345:e7054.
  • Chong LY, Head K, Hopkins C, Philpott C, Schilder AG, Burton MJ. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Cochrane Database Syst Rev. 2016 Apr 26;4(4):CD011996. doi: 10.1002/14651858.CD011996.pub2. PMID: 27115217; PMCID: PMC9393647.
  • Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on Rhinosinusitis and Nasal Polyps 2020. Rhinology. 2020 Feb 20;58(Suppl S29):1-464. doi: 10.4193/Rhin20.600. PMID: 32077450.
  • Piromchai P, Thanaviratananich S, Laopaiboon M. Systemic antibiotics for chronic rhinosinusitis without nasal polyps in adults. Cochrane Database of Systematic Reviews 2011, Issue 5. Art. No.: CD008233. DOI: 10.1002/14651858.CD008233.pub2.
  • Rank MA, Chu DK, Bognanni A, et al. The Joint Task Force on Practice Parameters GRADE guidelines for the medical management of chronic rhinosinusitis with nasal polyposis. J Allergy Clin Immunol 2023; 151:386.
  • Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015 Apr;152(2 Suppl):S1-S39.
  • Scadding GK, Durham SR, Mirakian R, Jones NS, Drake-Lee AB, Ryan D, et al. BSACI guidelines for the management of rhinosinusitis and nasal polyposis. Clin Exp Allergy 2008;38(2):260-75.
  • Snidvongs K, Kalish L, Sacks R, Craig JC, Harvey RJ. Topical steroid for chronic rhinosinusitis without polyps. Cochrane Database of Systematic Reviews 2011, Issue 8. Art. No.: CD009274. DOI: 10.1002/14651858.CD009274.

Sordera

Sordera súbita idiopática

  • Awad Z, Huins C, Pothier DD. Antivirals for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2012; CD006987
  • Chandrasekhar SS, Tsai Do BS, Schwartz SR, Bontempo LJ, Faucett EA, Finestone SA, et al. Clinical Practice Guideline: Sudden Hearing Loss (Update). Otolaryngol Head Neck Surg. 2019 Aug;161(1_suppl):S1-S45. doi: 10.1177/0194599819859885. PMID: 31369359.
  • Crane RA, Camilon M, Nguyen S, Meyer TA. Steroids for treatment of sudden sensorineural hearing loss: a meta-analysis of randomized controlled trials. Laringoscope 2015; 125(1): 209-17.
  • Maggie K, Selena E. Sudden sensorineural Hearinh Loss. A review of Daignosis, Treatment, and Prognosis. Trends Amplif. 2011; 15(3): 91-105.
  • Herrera M, García Berrocal JR, García Arumí A, Lavilla MJ, Plaza G; Grupo de Trabajo de la Comisión de Audiología de la SEORL. Update on consensus on diagnosis and treatment of idiopathic sudden sensorineural hearing loss. Acta Otorrinolaringol Esp (Engl Ed). 2019 Sep-Oct;70(5):290-300. English, Spanish. doi: 10.1016/j.otorri.2018.04.010. Epub 2018 Aug 6. PMID: 30093087.
  • Peter C Weber. Sudden sensorineural hearing loss. Literature review current through 2017. Uptodate 2017. Disponible en: http://www.uptodate.com
  • Schreiber B. Sudden sensorineural hearing loss. Lancet. 2010; 375 (9721): 1203-11.
  • Wei BP, Stathopoulos D, O'Leary S. Steroids for idiopathic sudden sensorineural hearing loss. Cochrane Database Syst Rev. 2013: CD003998.

Tapón de cera

  • Aaron K, Cooper TE, Warner L, Burton MJ. Ear drops for the removal of ear wax. Cochrane Database of Systematic Reviews 2018, Issue 7. Art. No.: CD012171. DOI: 10.1002/14651858.CD012171.pub2. Disponible en: https://www.cochrane.org/es/CD012171/gotas-oticas-para-la-eliminacion-del-cerumen
  • Aung T, Mulley GP. La eliminación de la cera del oído: 10 minutos de consulta. BMJ. 2002;325(7354):27-8.
  • Benito J, Garrido M, Velasco J, Mata M, Bachiller R, Ramírez B. Extracción de la cera de los oídos. Rev Pediatr Aten Primaria [Internet]. 2015 Sep [citado 2018 Oct 09] ; 17(67): 223-231. Disponible en: http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1139-76322015000400021&lng=es. http://dx.doi.org/10.4321/S1139-76322015000400021.
  • Hand C, Harvey I. The effectiveness of topical preparations for the treatment of earwax: a systematic review. British Journal of General Practice. 2004:54(508), 862-7.
  • Horton GA, Simpson MTW, Beyea MM, Beyea JA. Cerumen Management: An Updated Clinical Review and Evidence-Based Approach for Primary Care Physicians. J Prim Care Community Health. 2020 Jan-Dec;11:2150132720904181. doi: 10.1177/2150132720904181. PMID: 31994443; PMCID: PMC6990605.
  • Roland PS, Smith TL. Clinical pratice guideline: cerumen impaction. Otolaryngol Head Neck Surg. 2008 Sept;139(3 Suppl 2):S1-21 NGC.
  • Sarlat M. Tapones de cerumen. AMF 2007;3(3):166-70.

Xerostomía

  • Davies AN, Thompson J. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy. Cochrane Database of Systematic Reviews 2015, Issue 10. Art. No.: CD003782. DOI: 10.1002/14651858.CD003782.pub3. Accessed 12 October 2021. Disponible en: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD003782.pub3/full
  • Ramos-Casals M, Brito-Zerón P, Bombardieri S On behalf of the EULAR-Sjögren Syndrome Task Force Group, et al EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies Annals of the Rheumatic Diseases 2020;79:3-18.
  • Salum FG, Medella-Junior FAC, Figueiredo MAZ, Cherubini K. Salivary hypofunction: An update on therapeutic strategies. Gerodontology 2018; 35:305.
  • Plemons JM, Al-Hashimi I, Marek CL, American Dental Association Council on Scientific Affairs. Managing xerostomia and salivary gland hypofunction: executive summary of a report from the American Dental Association Council on Scientific Affairs. J Am Dent Assoc 2014; 145:867.